What are the recommended dilution guidelines for a 50 mg vial of tigecycline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tigecycline 50mg Dilution Guidelines

Reconstitute each 50mg vial with 5.3 mL of 0.9% Sodium Chloride, 5% Dextrose, or Lactated Ringer's solution to achieve a concentration of 10 mg/mL, then withdraw 5 mL of this reconstituted solution and add it to a 100 mL IV bag for infusion over 30-60 minutes. 1

Detailed Preparation Steps

Reconstitution Process

  • Add 5.3 mL of compatible diluent to each 50mg vial (note: vials contain 6% overage, so 5 mL of reconstituted solution = 50mg drug) 1
  • Gently swirl the vial until drug dissolves completely
  • Final concentration after reconstitution: 10 mg/mL

Compatible Diluents for Reconstitution

  • 0.9% Sodium Chloride Injection, USP
  • 5% Dextrose Injection, USP
  • Lactated Ringer's Injection, USP 1

Final Dilution for Infusion

  • Withdraw 5 mL of the reconstituted solution from the vial
  • Add to 100 mL IV bag for infusion
  • For 100mg dose: reconstitute two vials and add both to the 100 mL bag
  • For 50mg dose: reconstitute one vial and add to the 100 mL bag 1

Administration Parameters

Infusion Time

  • Administer over 30-60 minutes every 12 hours 1

Standard Dosing Regimen

  • Loading dose: 100 mg IV (first dose)
  • Maintenance: 50 mg IV every 12 hours 2, 1

Special Populations Requiring Dose Adjustment

Severe Hepatic Impairment (Child-Pugh C):

  • Loading dose: 100 mg IV
  • Reduced maintenance: 25 mg IV every 12 hours 1
  • No adjustment needed for mild-moderate hepatic impairment (Child-Pugh A/B)

Pediatric Patients (8-17 years):

  • Ages 8-11: 1.2 mg/kg IV every 12 hours (maximum 50 mg/dose)
  • Ages 12-17: 50 mg IV every 12 hours
  • Avoid use unless no alternatives available due to increased mortality risk in adults 1

Critical Safety Considerations

  • No preservatives in the formulation 1
  • No renal dose adjustment required 1
  • Tigecycline carries an FDA boxed warning for increased all-cause mortality (0.6% risk difference) 1
  • Reserve for situations when alternative treatments are not suitable 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.